The larger the node, the more important the role it plays in the network, and the top five targets contain AKT1, TNF, IL6, IL1B, and CASP3 (Table 2), which are not only important genes of THF for treating AIS but are also essential targets for experimental verification. This evidence concerns the gene AKT1 and androgen insensitivity syndrome.